Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 197

1.

Obese osteoarthritis patients exhibit an inflammatory synovial fibroblast phenotype, which is regulated by the long non coding RNA MALAT1.

Nanus DE, Wijesinghe SN, Pearson MJ, Hadjicharalambous MR, Rosser A, Davis ET, Lindsay MA, Jones SW.

Arthritis Rheumatol. 2019 Nov 4. doi: 10.1002/art.41158. [Epub ahead of print]

PMID:
31682073
2.

PRe-hospital Evaluation of Sensitive TrOponin (PRESTO) Study: multicentre prospective diagnostic accuracy study protocol.

Alghamdi A, Cook E, Carlton E, Siriwardena A, Hann M, Thompson A, Foulkes A, Phillips J, Cooper J, Bell S, Kirby K, Rosser A, Body R.

BMJ Open. 2019 Oct 28;9(10):e032834. doi: 10.1136/bmjopen-2019-032834.

3.

Insensitivity to loss predicts apathy in huntington's disease.

McLauchlan DJ, Lancaster T, Craufurd D, Linden DEJ, Rosser AE.

Mov Disord. 2019 Sep;34(9):1381-1391. doi: 10.1002/mds.27787. Epub 2019 Jul 30.

PMID:
31361357
4.

International Guidelines for the Treatment of Huntington's Disease.

Bachoud-Lévi AC, Ferreira J, Massart R, Youssov K, Rosser A, Busse M, Craufurd D, Reilmann R, De Michele G, Rae D, Squitieri F, Seppi K, Perrine C, Scherer-Gagou C, Audrey O, Verny C, Burgunder JM.

Front Neurol. 2019 Jul 3;10:710. doi: 10.3389/fneur.2019.00710. eCollection 2019.

5.

Physical Activity and Exercise Outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month Trial Within Cohort Evaluation of a Physical Activity Intervention in People With Huntington Disease.

Drew CJG, Quinn L, Hamana K, Williams-Thomas R, Marsh L, Dimitropoulou P, Playle R, Griffin BA, Kelson M, Schubert R, Muratori L, Reilmann R, Rosser A, Busse M.

Phys Ther. 2019 Sep 1;99(9):1201-1210. doi: 10.1093/ptj/pzz075.

PMID:
31101920
6.

Targeting Huntingtin Expression in Patients with Huntington's Disease.

Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, Wild EJ, Saft C, Barker RA, Blair NF, Craufurd D, Priller J, Rickards H, Rosser A, Kordasiewicz HB, Czech C, Swayze EE, Norris DA, Baumann T, Gerlach I, Schobel SA, Paz E, Smith AV, Bennett CF, Lane RM; Phase 1–2a IONIS-HTTRx Study Site Teams.

N Engl J Med. 2019 Jun 13;380(24):2307-2316. doi: 10.1056/NEJMoa1900907. Epub 2019 May 6. Erratum in: N Engl J Med. 2019 Oct 3;381(14):1398.

PMID:
31059641
7.

Clinical Presentation and Features of Juvenile-Onset Huntington's Disease: A Systematic Review.

Cronin T, Rosser A, Massey T.

J Huntingtons Dis. 2019;8(2):171-179. doi: 10.3233/JHD-180339.

PMID:
31045518
8.

Teaching practicing surgeons what not to do: An analysis of instruction fluidity during a simulation-based continuing medical education course.

Godfrey M, Rosser AA, Pugh CM, Shaffer DW, Sachdeva AK, Jung SA.

Surgery. 2019 Jun;165(6):1082-1087. doi: 10.1016/j.surg.2019.01.016. Epub 2019 Mar 12.

PMID:
30876670
9.

The surgical consult entrustable professional activity (EPA): Defining competence as a basis for evaluation.

Stucke RS, Sorensen M, Rosser A, Sullivan S.

Am J Surg. 2018 Dec 31. pii: S0002-9610(18)30522-1. doi: 10.1016/j.amjsurg.2018.12.056. [Epub ahead of print]

PMID:
30616922
10.

What do you want to know? Operative experience predicts the type of questions practicing surgeons ask during a CME laparoscopic hernia repair course.

Godfrey M, Rosser AA, Pugh CM, Sachdeva AK, Sullivan S.

Am J Surg. 2019 Feb;217(2):382-386. doi: 10.1016/j.amjsurg.2018.11.027. Epub 2018 Nov 27.

PMID:
30527925
11.

Heteroatom Substitution at Amide Nitrogen-Resonance Reduction and HERON Reactions of Anomeric Amides.

Glover SA, Rosser AA.

Molecules. 2018 Oct 31;23(11). pii: E2834. doi: 10.3390/molecules23112834. Review.

12.

Automated Assessment of Movement Impairment in Huntington's Disease.

Bennasar M, Hicks YA, Clinch SP, Jones P, Holt C, Rosser A, Busse M.

IEEE Trans Neural Syst Rehabil Eng. 2018 Oct;26(10):2062-2069. doi: 10.1109/TNSRE.2018.2868170.

13.

Outcome of cell suspension allografts in a patient with Huntington's disease.

Maxan A, Mason S, Saint-Pierre M, Smith E, Ho A, Harrower T, Watts C, Tai Y, Pavese N, Savage JC, Tremblay MÈ, Gould P, Rosser AE, Dunnett SB, Piccini P, Barker RA, Cicchetti F.

Ann Neurol. 2018 Dec;84(6):950-956. doi: 10.1002/ana.25354. Epub 2018 Oct 25.

14.

Oxygen producing microscale spheres affect cell survival in conditions of oxygen-glucose deprivation in a cell specific manner: implications for cell transplantation.

Newland H, Eigel D, Rosser AE, Werner C, Newland B.

Biomater Sci. 2018 Sep 25;6(10):2571-2577. doi: 10.1039/c8bm00490k.

15.

The ACUTE (Ambulance CPAP: Use, Treatment effect and economics) feasibility study: a pilot randomised controlled trial of prehospital CPAP for acute respiratory failure.

Fuller GW, Goodacre S, Keating S, Perkins G, Ward M, Rosser A, Gunson I, Miller J, Bradburn M, Thokala P, Harris T, Carson A, Marsh M, Cooper C.

Pilot Feasibility Stud. 2018 Jun 18;4:86. doi: 10.1186/s40814-018-0281-9. eCollection 2018.

16.

Rethinking Functional Outcome Measures: The Development of a Novel Upper Limb Token Transfer Test to Assess Basal Ganglia Dysfunction.

Clinch SP, Busse M, Lelos MJ, Rosser AE.

Front Neurosci. 2018 May 30;12:366. doi: 10.3389/fnins.2018.00366. eCollection 2018.

17.

Dissection and Preparation of Human Primary Fetal Ganglionic Eminence Tissue for Research and Clinical Applications.

Roberton VH, Rosser AE, McGorrian AM, Precious SV.

Methods Mol Biol. 2018;1780:573-583. doi: 10.1007/978-1-4939-7825-0_26.

PMID:
29856036
18.

Kv7 channels are upregulated during striatal neuron development and promote maturation of human iPSC-derived neurons.

Telezhkin V, Straccia M, Yarova P, Pardo M, Yung S, Vinh NN, Hancock JM, Barriga GG, Brown DA, Rosser AE, Brown JT, Canals JM, Randall AD, Allen ND, Kemp PJ.

Pflugers Arch. 2018 Sep;470(9):1359-1376. doi: 10.1007/s00424-018-2155-7. Epub 2018 May 24.

19.

Pallidal deep brain stimulation in juvenile Huntington's disease: local field potential oscillations and clinical data.

Ferrea S, Groiss SJ, Elben S, Hartmann CJ, Dunnett SB, Rosser A, Saft C, Schnitzler A, Vesper J, Wojtecki L; Surgical Approaches Working Group of the European Huntington’s Disease Network (EHDN).

J Neurol. 2018 Jul;265(7):1573-1579. doi: 10.1007/s00415-018-8880-1. Epub 2018 May 3.

PMID:
29725840
20.

Alterations in the metabolic and cardiorespiratory response to exercise in Huntington's Disease.

Steventon JJ, Collett J, Furby H, Hamana K, Foster C, O'Callaghan P, Dennis A, Armstrong R, Németh AH, Rosser AE, Murphy K, Quinn L, Busse M, Dawes H.

Parkinsonism Relat Disord. 2018 Sep;54:56-61. doi: 10.1016/j.parkreldis.2018.04.014. Epub 2018 Apr 14.

PMID:
29705557
21.

The Effect of Tissue Preparation and Donor Age on Striatal Graft Morphology in the Mouse.

Harrison DJ, Roberton VH, Vinh NN, Brooks SP, Dunnett SB, Rosser AE.

Cell Transplant. 2018 Feb;27(2):230-244. doi: 10.1177/0963689717744788.

22.

Recurrent tuberculosis in the pre-elimination era.

Rosser A, Marx FM, Pareek M.

Int J Tuberc Lung Dis. 2018 Feb 1;22(2):139-150. doi: 10.5588/ijtld.17.0590. Review.

PMID:
29506610
23.

A nested case-control study of predictors for tuberculosis recurrence in a large UK Centre.

Rosser A, Richardson M, Wiselka MJ, Free RC, Woltmann G, Mukamolova GV, Pareek M.

BMC Infect Dis. 2018 Feb 27;18(1):94. doi: 10.1186/s12879-017-2933-4.

24.

Exploring computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD): protocol for a randomised feasibility study.

Yhnell E, Furby H, Breen RS, Brookes-Howell LC, Drew CJG, Playle R, Watson G, Metzler-Baddeley C, Rosser AE, Busse ME.

Pilot Feasibility Stud. 2018 Feb 6;4:45. doi: 10.1186/s40814-018-0237-0. eCollection 2018.

25.

Pulmonary Diseases in Refugees and Migrants in Europe.

Olaru ID, Van Den Broucke S, Rosser AJ, Salzer HJF, Woltmann G, Bottieau E, Lange C.

Respiration. 2018;95(4):273-286. doi: 10.1159/000486451. Epub 2018 Feb 7. Review.

26.

The hands and head of a surgeon: Modeling operative competency with multimodal epistemic network analysis.

Ruis AR, Rosser AA, Quandt-Walle C, Nathwani JN, Shaffer DW, Pugh CM.

Am J Surg. 2018 Nov;216(5):835-840. doi: 10.1016/j.amjsurg.2017.11.027. Epub 2017 Dec 2.

PMID:
29224911
27.

Differentially Culturable Tubercule Bacilli Are Generated during Nonpulmonary Tuberculosis Infection.

Rosser A, Pareek M, Turapov O, Wiselka MJ, Mukamolova GV.

Am J Respir Crit Care Med. 2018 Mar 15;197(6):818-821. doi: 10.1164/rccm.201705-1048LE. No abstract available.

28.

Clinical characterization of dystonia in adult patients with Huntington's disease.

van de Zande NA, Massey TH, McLauchlan D, Pryce Roberts A, Zutt R, Wardle M, Payne GC, Clenaghan C, Tijssen MAJ, Rosser AE, Peall KJ.

Eur J Neurol. 2017 Sep;24(9):1140-1147. doi: 10.1111/ene.13349. Epub 2017 Jun 29.

PMID:
28661018
29.

Myelin Breakdown in Human Huntington's Disease: Multi-Modal Evidence from Diffusion MRI and Quantitative Magnetization Transfer.

Bourbon-Teles J, Bells S, Jones DK, Coulthard E, Rosser A, Metzler-Baddeley C.

Neuroscience. 2019 Apr 1;403:79-92. doi: 10.1016/j.neuroscience.2017.05.042. Epub 2017 Jun 1.

30.

Pluripotent stem cell-derived neurons for transplantation in Huntington's disease.

Li M, Rosser AE.

Prog Brain Res. 2017;230:263-281. doi: 10.1016/bs.pbr.2017.02.009. Epub 2017 May 2. Review.

PMID:
28552232
31.

Reprogramming the diseased brain.

Dunnett SB, Rosser AE.

Nat Biotechnol. 2017 May 9;35(5):426-428. doi: 10.1038/nbt.3869. No abstract available.

PMID:
28486448
32.

Prehospital randomised assessment of a mechanical compression device in out-of-hospital cardiac arrest (PARAMEDIC): a pragmatic, cluster randomised trial and economic evaluation.

Gates S, Lall R, Quinn T, Deakin CD, Cooke MW, Horton J, Lamb SE, Slowther AM, Woollard M, Carson A, Smyth M, Wilson K, Parcell G, Rosser A, Whitfield R, Williams A, Jones R, Pocock H, Brock N, Black JJ, Wright J, Han K, Shaw G, Blair L, Marti J, Hulme C, McCabe C, Nikolova S, Ferreira Z, Perkins GD.

Health Technol Assess. 2017 Mar;21(11):1-176. doi: 10.3310/hta21110.

33.

Physical Activity Self-Management and Coaching Compared to Social Interaction in Huntington Disease: Results From the ENGAGE-HD Randomized, Controlled Pilot Feasibility Trial.

Busse M, Quinn L, Drew C, Kelson M, Trubey R, McEwan K, Jones C, Townson J, Dawes H, Tudor-Edwards R, Rosser A, Hood K.

Phys Ther. 2017 Jun 1;97(6):625-639. doi: 10.1093/ptj/pzx031.

34.

Resuscitation-promoting factors are important determinants of the pathophysiology in Mycobacterium tuberculosis infection.

Rosser A, Stover C, Pareek M, Mukamolova GV.

Crit Rev Microbiol. 2017 Sep;43(5):621-630. doi: 10.1080/1040841X.2017.1283485. Epub 2017 Feb 17. Review.

PMID:
28338360
35.

Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington's disease?

Precious SV, Zietlow R, Dunnett SB, Kelly CM, Rosser AE.

Neurochem Int. 2017 Jun;106:114-121. doi: 10.1016/j.neuint.2017.01.016. Epub 2017 Jan 27. Review.

36.

Insights in spatio-temporal characterization of human fetal neural stem cells.

Martín-Ibáñez R, Guardia I, Pardo M, Herranz C, Zietlow R, Vinh NN, Rosser A, Canals JM.

Exp Neurol. 2017 May;291:20-35. doi: 10.1016/j.expneurol.2017.01.011. Epub 2017 Jan 25.

PMID:
28131724
37.

Integrating technology into complex intervention trial processes: a case study.

Drew CJ, Poile V, Trubey R, Watson G, Kelson M, Townson J, Rosser A, Hood K, Quinn L, Busse M.

Trials. 2016 Nov 17;17(1):551.

38.

Can manipulation of differentiation conditions eliminate proliferative cells from a population of ES cell-derived forebrain cells?

Precious SV, Kelly CM, Allen ND, Rosser AE.

Neurogenesis (Austin). 2016 Jan 11;3(1):e1127311. doi: 10.1080/23262133.2015.1127311. eCollection 2016.

39.

Longitudinal in vivo MRI in a Huntington's disease mouse model: Global atrophy in the absence of white matter microstructural damage.

Steventon JJ, Trueman RC, Ma D, Yhnell E, Bayram-Weston Z, Modat M, Cardoso J, Ourselin S, Lythgoe M, Stewart A, Rosser AE, Jones DK.

Sci Rep. 2016 Sep 1;6:32423. doi: 10.1038/srep32423.

40.

Human t-DARPP is induced during striatal development.

Straccia M, Carrere J, Rosser AE, Canals JM.

Neuroscience. 2016 Oct 1;333:320-30. doi: 10.1016/j.neuroscience.2016.07.022. Epub 2016 Jul 28.

41.

Motor-cognitive dual-task deficits in individuals with early-mid stage Huntington disease.

Fritz NE, Hamana K, Kelson M, Rosser A, Busse M, Quinn L.

Gait Posture. 2016 Sep;49:283-289. doi: 10.1016/j.gaitpost.2016.07.014. Epub 2016 Jul 17.

PMID:
27474949
42.

The societal cost of Huntington's disease: are we underestimating the burden?

Jones C, Busse M, Quinn L, Dawes H, Drew C, Kelson M, Hood K, Rosser A, Edwards RT.

Eur J Neurol. 2016 Oct;23(10):1588-90. doi: 10.1111/ene.13107. Epub 2016 Jul 27.

43.

A randomized, controlled trial of a multi-modal exercise intervention in Huntington's disease.

Quinn L, Hamana K, Kelson M, Dawes H, Collett J, Townson J, Roos R, van der Plas AA, Reilmann R, Frich JC, Rickards H, Rosser A, Busse M.

Parkinsonism Relat Disord. 2016 Oct;31:46-52. doi: 10.1016/j.parkreldis.2016.06.023. Epub 2016 Jul 1.

44.

Respiratory decline is integral to disease progression in Huntington's disease.

Jones U, Busse M, Enright S, Rosser AE.

Eur Respir J. 2016 Aug;48(2):585-8. doi: 10.1183/13993003.02215-2015. Epub 2016 Jun 23. No abstract available.

45.

FoxP1 marks medium spiny neurons from precursors to maturity and is required for their differentiation.

Precious SV, Kelly CM, Reddington AE, Vinh NN, Stickland RC, Pekarik V, Scherf C, Jeyasingham R, Glasbey J, Holeiter M, Jones L, Taylor MV, Rosser AE.

Exp Neurol. 2016 Aug;282:9-18. doi: 10.1016/j.expneurol.2016.05.002. Epub 2016 May 3.

46.

Prevalence and predictors of hospital prealerting in acute stroke: a mixed methods study.

Sheppard JP, Lindenmeyer A, Mellor RM, Greenfield S, Mant J, Quinn T, Rosser A, Sandler D, Sims D, Ward M, McManus RJ; CLAHRC BBC investigators.

Emerg Med J. 2016 Jul;33(7):482-8. doi: 10.1136/emermed-2014-204392. Epub 2016 Feb 23.

47.

Development and Delivery of a Physical Activity Intervention for People With Huntington Disease: Facilitating Translation to Clinical Practice.

Quinn L, Trubey R, Gobat N, Dawes H, Edwards RT, Jones C, Townson J, Drew C, Kelson M, Poile V, Rosser A, Hood K, Busse M.

J Neurol Phys Ther. 2016 Apr;40(2):71-80. doi: 10.1097/NPT.0000000000000119.

48.

Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease.

Lelos MJ, Morgan RJ, Kelly CM, Torres EM, Rosser AE, Dunnett SB.

Exp Neurol. 2016 Apr;278:54-61. doi: 10.1016/j.expneurol.2016.02.003. Epub 2016 Feb 4.

49.

Using Actiwatch to monitor circadian rhythm disturbance in Huntington' disease: A cautionary note.

Townhill J, Hughes AC, Thomas B, Busse ME, Price K, Dunnett SB, Hastings MH, Rosser AE.

J Neurosci Methods. 2016 May 30;265:13-8. doi: 10.1016/j.jneumeth.2016.01.009. Epub 2016 Jan 14.

50.

Synthesis of ROS scavenging microspheres from a dopamine containing poly(β-amino ester) for applications for neurodegenerative disorders.

Newland B, Wolff P, Zhou D, Wang W, Zhang H, Rosser A, Wang W, Werner C.

Biomater Sci. 2016 Mar;4(3):400-4. doi: 10.1039/c5bm00542f.

Supplemental Content

Loading ...
Support Center